SAFE (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) Study

NCT02959606 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

272

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Arterial Disease

Interventions

DRUG: Sarpogrelate SR 300mg
DRUG: Clopidogrel

Sponsor

Seoul National University Hospital